Patent litigation remains prolific in the life sciences industry as ensuring protection becomes more challenging and complex due to the involvement of technologies. Some issues plaguing patent owners and intellectual property (IP) lawyers concern the Section 101 jurisprudence related to innovations in the life sciences industry. Moreover, landmark cases like Amgen Inc. v. Sanofi continue to shape the patent landscape, posing profound impacts on invention enablement. These and other developments continue to pose risks that practitioners should be wary of. Canadian jurisprudence deals with similar issues and in some cases, patent practice diverges between the US and Canada.
Listen as experienced patent attorneys Melanie Szweras (Bereskin & Parr LLP) and Kevin E. Noonan, Ph.D. (McDonnell Boehnen Hulbert & Berghoff LLP) provide a comprehensive discussion of the latest trends and challenges in protecting patents in the life science sector. Speakers, among other things, will offer practical tips and strategies for navigating this dynamic regulatory environment.
Key topics include:
- Life Science Patents: Latest Regulatory Developments in the US and Canada
- Current Challenges and Regulatory Issues Faced by Patent Owners and IP Lawyers
- Notable Cases in the US and Canada
- What Lies Ahead.
Patent Protection in Life Sciences: Creative Approaches to Safeguard Your Innovations
Date+Time:
Wednesday, September 27, 2023
12:00 pm to 1:00 pm (ET)
Register now for this free continuing legal education webinar!
By:
The Knowledge Group
Speakers:
- Melanie Szweras
- Kevin E. Noonan, Ph.D.
- New York: 1.0 credits
- California: The Knowledge Group is an approved Multiple Activity Provider in the state of California thus, TKG programs are presumptively approved.
- Most Other States: TKG links to How to Claim CLE Credits Per State.
No comments:
Post a Comment